Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1990. Upgrade now.
Date Value
September 30, 2024 -2.425B
June 30, 2024 1.216B
March 31, 2024 -2.814B
December 31, 2023 -2.245B
September 30, 2023 -4.269B
June 30, 2023 3.758B
March 31, 2023 -2.054B
December 31, 2022 -1.554B
September 30, 2022 -2.702B
June 30, 2022 -1.777B
March 31, 2022 -3.086B
December 31, 2021 5.207B
September 30, 2021 -2.274B
June 30, 2021 1.758B
March 31, 2021 -2.098B
December 31, 2020 1.372B
September 30, 2020 -3.851B
June 30, 2020 1.137B
March 31, 2020 -1.49B
December 31, 2019 -2.011B
September 30, 2019 -3.152B
June 30, 2019 -2.084B
March 31, 2019 -1.614B
December 31, 2018 -5.566B
September 30, 2018 -1.905B
Date Value
June 30, 2018 -2.967B
March 31, 2018 -2.722B
December 31, 2017 -5.785B
September 30, 2017 536.00M
June 30, 2017 -6.218B
March 31, 2017 1.461B
December 31, 2016 -1.977B
September 30, 2016 -835.00M
June 30, 2016 -3.366B
March 31, 2016 -2.866B
December 31, 2015 -2.406B
September 30, 2015 -2.539B
June 30, 2015 -5.597B
March 31, 2015 5.155B
December 31, 2014 -9.772B
September 30, 2014 1.279B
June 30, 2014 -8.369B
March 31, 2014 1.62B
December 31, 2013 -2.624B
September 30, 2013 -2.915B
June 30, 2013 970.00M
March 31, 2013 -1.421B
December 31, 2012 -1.218B
September 30, 2012 -738.00M
June 30, 2012 -586.00M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-4.269B
Minimum
Sep 2023
5.207B
Maximum
Dec 2021
-1.010B
Average
-2.032B
Median

Cash from Financing (Quarterly) Benchmarks

Amgen Inc -3.651B
Johnson & Johnson -9.882B
Eli Lilly and Co 211.30M
Pfizer Inc -4.636B
Moderna Inc 11.00M